Naproxen reversibly inhibits cyclooxygenase-1 and -2, decreasing conversion of arachidonic acid to prostaglandins that mediate fever, pain, and inflammation. Its longer half-life (12–17 hours) supports twice-daily dosing for sustained anti-inflammatory effect in chronic conditions such as juvenile idiopathic arthritis.